Abstract
Studies of recombinant interleukin-2 (RIL-2) administered by continuous intravenous infusion revealed hepatocellular toxicity and redistribution of lymphoid cells. This finding was different from the normal findings seen in rats receiving comparable infusions of the vehicle.
Original language | English (US) |
---|---|
Pages (from-to) | 537-541 |
Number of pages | 5 |
Journal | Journal of the National Medical Association |
Volume | 79 |
Issue number | 5 |
State | Published - 1987 |
Externally published | Yes |
ASJC Scopus subject areas
- Medicine(all)